Dr. Vineet Mishra is a distinguished Nuclear Medicine physician with specialised expertise in nuclear oncology and advanced nuclear medicine therapies. He has been extensively trained at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, where he developed strong clinical and research experience in thyroid cancer, radioactive iodine therapy, and tyrosine kinase inhibitor-based treatments. His clinical expertise encompasses comprehensive diagnostic nuclear oncology, including advanced PET-CT imaging modalities such as FDG, PSMA, DOTANOC, FAPI, FDOPA, choline, and other novel tracers, along with metabolic image-guided biopsy techniques. Dr. Mishra has hands-on experience in a wide range of radionuclide therapies including radioactive iodine therapy, Lutetium-PSMA, Lutetium-DOTATATE, Lutetium-FAPI, Yttrium-90 TARE, Terbium-based therapies, and Actinium-PSMA targeted therapies. His clinical interests also extend to nuclear cardiology and nuclear neurology, including cardiac viability studies, radionuclide stress imaging, and brain PET imaging for dementia and autoimmune neurological disorders.
Nuclear oncology including PET-CT based diagnostics and metabolic biopsy
Nuclear medicine therapies including Lutetium, Actinium, and Terbium-based treatments
Thyroid disorders including thyroid cancer and radioactive iodine therapy
Prostate cancer and neuroendocrine tumours
Hepatocellular carcinoma and metastatic cancers
Nuclear cardiology including myocardial viability and stress imaging
Nuclear neurology including dementia and brain PET imaging
MBBS | MD - Nuclear Medicine
Derived from verified patient bills.
Dr. Vineet Mishra is a distinguished Nuclear Medicine physician with specialised expertise in nuclear oncology and advanced nuclear medicine therapies. He has been extensively trained at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, where he developed strong clinical and research experience in thyroid cancer, radioactive iodine therapy, and tyrosine kinase inhibitor-based treatments. His clinical expertise encompasses comprehensive diagnostic nuclear oncology, including advanced PET-CT imaging modalities such as FDG, PSMA, DOTANOC, FAPI, FDOPA, choline, and other novel tracers, along with metabolic image-guided biopsy techniques. Dr. Mishra has hands-on experience in a wide range of radionuclide therapies including radioactive iodine therapy, Lutetium-PSMA, Lutetium-DOTATATE, Lutetium-FAPI, Yttrium-90 TARE, Terbium-based therapies, and Actinium-PSMA targeted therapies. His clinical interests also extend to nuclear cardiology and nuclear neurology, including cardiac viability studies, radionuclide stress imaging, and brain PET imaging for dementia and autoimmune neurological disorders.
Co-authored Tomio Award Paper at Asia Oceania Congress of Nuclear Medicine and Biology, 2025
